Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jul;9(7):857-79.
doi: 10.1586/eri.11.59.

Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects

Tianhong Dai  1 , Masamitsu Tanaka, Ying-Ying Huang, Michael R Hamblin
Affiliations
Review

Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects

Tianhong Dai et al. Expert Rev Anti Infect Ther. 2011 Jul.

Erratum in

  • Expert Rev Anti Infect Ther. 2013 Aug;11(8):866

Abstract

Since its discovery approximately 200 years ago, chitosan, as a cationic natural polymer, has been widely used as a topical dressing in wound management owing to its hemostatic, stimulation of healing, antimicrobial, nontoxic, biocompatible and biodegradable properties. This article covers the antimicrobial and wound-healing effects of chitosan, as well as its derivatives and complexes, and its use as a vehicle to deliver biopharmaceuticals, antimicrobials and growth factors into tissue. Studies covering applications of chitosan in wounds and burns can be classified into in vitro, animal and clinical studies. Chitosan preparations are classified into native chitosan, chitosan formulations, complexes and derivatives with other substances. Chitosan can be used to prevent or treat wound and burn infections not only because of its intrinsic antimicrobial properties, but also by virtue of its ability to deliver extrinsic antimicrobial agents to wounds and burns. It can also be used as a slow-release drug-delivery vehicle for growth factors to improve wound healing. The large number of publications in this area suggests that chitosan will continue to be an important agent in the management of wounds and burns.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Preparation of chitosan from chitin
(A) Preparation of chitosan from chitin by alkaline deacetylation. (B) Preparation of chitosan from chitin by enzymatic deacetylation.
Figure 2
Figure 2
Schematic depiction of the applications of chitosan in wound-healing and burn therapy, showing it can be usefully applied ‘from head to toe’.
Figure 3
Figure 3. Treatment of mouse burn infections using a chitosan acetate bandage
(A) Representative successive bioluminescence images from days 0–3 of mice with Pseudomonas aeruginosa-infected burns with no treatment, treated with silver dressing and treated with chitosan acetate bandage. The inset at day 3 in silver dressing burn shows the bioluminescence signal after the dressing was removed from a dead mouse. (B) Survival curves of mice with P. aeruginosa-infected burns treated with chitosan acetate bandage (n = 15), silver dressing (n = 11) or no treatment (n = 15). (C) Survival curves of mice with Proteus mirabilis-infected burn treated with chitosan acetate bandage (n = 12), silver dressing (n = 8) or no treatment (n = 13). Reprinted from [21] with permission.
Figure 4
Figure 4. The phases of cutaneous wound healing
(A) Immediately following cutaneous injury, blood elements and amines extravasate from locally damaged blood vessels within the dermis. Vascular permeability is temporarily increased to allow neutrophils (PMNs), platelets and plasma proteins to infiltrate the wound. Vasoconstriction follows, in response to factors released by these cells. (B) Coagulation then occurs as platelets aggregate with fibrin, which is deposited in the wound following its conversion from fibrinogen. (C) Platelets release several factors, including PDGF and TGF-β, which attract PMNs to the wound, signaling the beginning of inflammation. (D) After 48 h, macrophages replace PMNs as the principal inflammatory cell. Together, PMNs and macrophages remove debris from the wound, release growth factors and begin to reorganize the extracellular matrix. (E) The proliferation phase begins at about 72 h as fibroblasts, recruited to the wound by growth factors released by inflammatory cells, begin to synthesize collagen, and angiogenesis and re-epitheliazation occurs. (F) Collagen crosslinking and reorganization occur for months after injury in the remodeling phase of repair. Chitosan has been reported to beneficially influence stages (B–E). PMN: Polymorphonuclear leukocyte. Reproduced with permission from [108].
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Labrude P, Becq C. Pharmacist and chemist Henri Braconnot. Rev Hist Pharm (Paris) 2003;51(337):61–78. - PubMed
    1. Kozen BG, Kircher SJ, Henao J, et al. An alternative hemostatic dressing: comparison of CELOX, HemCon, and QuikClot. Acad Emerg Med. 2008;15(1):74–81. - PubMed
    1. Millner RW, Lockhart AS, Bird H, et al. A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery. Ann Thorac Surg. 2009;87(2):e13–e14. Demonstrates the mechanism of antimicrobial effects of chitosan. - PubMed
    1. Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev. 2001;52(2):105–115. - PubMed
    1. Rabea EI, Badawy ME, Stevens CV, et al. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules. 2003;4(6):1457–1465. Demonstrates the mechanism of antimicrobial effects of chitosan. - PubMed

Publication types

MeSH terms